Published in J Thorac Cardiovasc Surg on March 01, 1991
Emergency cardiopulmonary bypass support in patients with severe cardiogenic shock after acute myocardial infarction. Heart Vessels (1996) 0.97
Earlier application of percutaneous cardiopulmonary support rescues patients from severe cardiopulmonary failure using the APACHE III scoring system. J Korean Med Sci (2009) 0.83
Practice characteristics of Emergency Department extracorporeal cardiopulmonary resuscitation (eCPR) programs in the United States: The current state of the art of Emergency Department extracorporeal membrane oxygenation (ED ECMO). Resuscitation (2016) 0.81
Development of a pulsatile flow-generating circulatory-assist device. J Artif Organs (2010) 0.76
Successful myocardial revascularization and neurologic recovery in a patient with prolonged refractory cardiac arrest and a chronically occluded left internal carotid artery. Tex Heart Inst J (1995) 0.76
Extracorporeal cardiopulmonary resuscitation. Ann Transl Med (2017) 0.75
Pulsatile reperfusion after cardiac arrest improves neurologic outcome. Ann Surg (1991) 0.75
An analysis of time delays preceding thrombolysis for acute myocardial infarction. JAMA (1989) 3.10
Clinical use of the total artificial heart. N Engl J Med (1984) 2.94
Anesthetic considerations for patients undergoing minimally invasive coronary artery bypass surgery: mini-sternotomy and mini-thoracotomy approaches. J Cardiothorac Vasc Anesth (1996) 2.66
Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med (1989) 2.26
Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy. Correlation with disease severity and cardiac autoantibodies. Circulation (1995) 2.11
Safety and efficacy of off-pump coronary artery bypass grafting. Ann Thorac Surg (2000) 1.93
Cardiac asystole: a manifestation of neurally mediated hypotension-bradycardia. J Am Coll Cardiol (1989) 1.72
Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy. Circ Res (1989) 1.72
Management of flail chest without mechanical ventilation. Ann Thorac Surg (1975) 1.70
Minimally invasive mitral operations. Ann Thorac Surg (1997) 1.62
Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty. Am J Cardiol (1991) 1.62
Affairs of the wounded heart: penetrating cardiac wounds. J Trauma (1979) 1.56
Mini-sternotomy for coronary artery bypass grafting. Ann Thorac Surg (1996) 1.52
Treatment of femoral fractures in children by pediatric orthopedists: results of a 1998 survey. J Pediatr Orthop (2001) 1.52
Does multivessel, off-pump coronary artery bypass reduce postoperative morbidity? Ann Thorac Surg (2000) 1.49
Bidirectional crossover and late outcome after coronary angioplasty and bypass surgery: 8 to 11 year follow-up. J Am Coll Cardiol (1990) 1.45
Management of cerebral palsy with botulinum-A toxin: preliminary investigation. J Pediatr Orthop (1993) 1.41
Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial. J Pediatr Orthop (1994) 1.41
Objective evaluation of the efficacy of various venous cannulas. J Thorac Cardiovasc Surg (1981) 1.38
Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group. J Pediatr Orthop (2000) 1.33
Chylothorax after median sternotomy for intrapericardial cardiac surgery. J Thorac Cardiovasc Surg (1976) 1.23
Calcium uptake by cardiac sarcoplasmic reticulum in human dilated cardiomyopathy. Cardiovasc Res (1987) 1.12
Selection of patients for cardiac transplantation. Circulation (1987) 1.03
Prophylactic antibiotics in the treatment of penetrating chest wounds. A prospective double-blind study. J Thorac Cardiovasc Surg (1977) 1.03
Ten years' experience with the St. Jude Medical valve prosthesis. Ann Thorac Surg (1989) 1.03
Subxiphoid pericardial window in patients with suspected traumatic pericardial tamponade. Ann Thorac Surg (1977) 1.03
Clinical and hemodynamic results with the St. Jude Medical cardiac valve prosthesis. A three-year experience. J Thorac Cardiovasc Surg (1981) 1.00
Aorto-coronary vein fistula. A complication of coronary artery bypass graft surgery. Chest (1981) 0.99
A new cardiac prosthesis: the St. Jude Medical cardiac valve: in vivo results. Circulation (1979) 0.98
Is serum creatine kinase-MB in electrically injured patients predictive of myocardial injury? JAMA (1986) 0.97
Is low ejection fraction safe for off-pump coronary bypass operation? Ann Thorac Surg (2000) 0.95
Mitral valve replacement with the Hancock bioprosthesis: five- to ten-year follow-up. Ann Thorac Surg (1981) 0.94
Traumatic pulmonary arteriovenous fistula. J Thorac Cardiovasc Surg (1975) 0.94
Diagnosis and management of major tracheobronchial injuries. Ann Thorac Surg (1979) 0.93
Cost-effectiveness of minimally invasive coronary artery bypass surgery. Ann Thorac Surg (1999) 0.93
Thrombolytic therapy of left-sided prosthetic valve thrombosis. Chest (1995) 0.92
St. Jude Medical cardiac valve prosthesis: in vitro studies. J Thorac Cardiovasc Surg (1979) 0.92
Analysis of risk factors for acute allograft rejection after heart transplantation. J Heart Transplant (1990) 0.90
Six years of experience with the St. Jude Medical valvular prosthesis. Circulation (1985) 0.90
Experimental evaluation of reexpansion pulmonary edema. Ann Thorac Surg (1978) 0.90
Cost-effectiveness and predictors of early extubation. Ann Thorac Surg (1995) 0.88
A multicenter, randomized, controlled trial of Celsior for flush and hypothermic storage of cardiac allografts. Ann Thorac Surg (2001) 0.88
Catheter-induced delayed recurrent pulmonary artery hemorrhage. Intervention with therapeutic embolism of the pulmonary artery. JAMA (1989) 0.88
Heart transplantation in Arizona. J Heart Transplant (1985) 0.88
Changes in health-related quality of life and depression in heart transplant recipients. J Heart Lung Transplant (1995) 0.88
Possible involvement of the HLA-DQB1 gene in susceptibility and resistance to human dilated cardiomyopathy. Am Heart J (1995) 0.86
St. Jude Medical prosthesis: valve-related deaths and complications. Ann Thorac Surg (1987) 0.86
Gastrointestinal complications after human transplantation and mechanical heart replacement. Am J Surg (1989) 0.86
Warm heart surgery: a prospective comparison between normothermic and tepid temperature. J Card Surg (1995) 0.85
Evaluation of the mechanism of zymosan-induced resistance to experimental peritonitis. Surgery (1978) 0.85
Aberrant left pulmonary artery presenting as a right paratracheal mass in an adult. J Thorac Cardiovasc Surg (1976) 0.84
The influence of prophylactic antibiotics on the warfarin anticoagulation response in the postoperative prosthetic cardiac valve patient. Cefamandole versus vancomycin. Ann Surg (1984) 0.84
Cardiac transplantation in patients over 50 years of age. J Am Coll Cardiol (1986) 0.84
Thromboembolic complications of the Jarvik-7 total artificial heart: case report. Artif Organs (1986) 0.84
The total artificial heart as a bridge to transplantation. A report of two cases. JAMA (1986) 0.84
Comparison of porcine valve xenografts with mechanical prostheses. A 7 1/2 year experience. J Thorac Cardiovasc Surg (1984) 0.83
Pulmonary artery aneurysm. Am Surg (1978) 0.83
Comparison between port-access and less invasive valve surgery. Ann Thorac Surg (1999) 0.83
Transthoracic approach for Pott's disease. Ann Thorac Surg (1976) 0.83
Should valve replacement and related procedures be performed in elderly patients? Ann Thorac Surg (1984) 0.83
How much does aortic and pulmonary artery area vary during the cardiac cycle? Am Heart J (1987) 0.83
Prolactin as a marker of rejection in human heart transplantation. Transplant Proc (1987) 0.82
The Bezold reflex: a special case of the left ventricular mechanoreceptor reflex. Proc Natl Acad Sci U S A (1979) 0.82
Exclusion of atrial thrombus by transesophageal echocardiography. J Am Soc Echocardiogr (1992) 0.82
Hemodynamic effects of infused arginine vasopressin in congestive heart failure. J Am Coll Cardiol (1986) 0.82
Regional myocardial blood flow during exercise in dogs with chronic left ventricular hypertrophy. Circ Res (1981) 0.82
Prolactin as a marker of rejection in human heart transplantation. J Heart Transplant (1988) 0.82
Heterogeneous myocardial catecholamine concentrations in patients with congestive heart failure. Am J Cardiol (1987) 0.82
Transesophageal color Doppler echocardiography of the normal St. Jude Medical mitral valve prosthesis. Am Heart J (1991) 0.82
Intra-aortic balloon counterpulsation support for elective coronary angioplasty in the setting of poor left ventricular function: a two center experience. J Invasive Cardiol (1992) 0.81
Ten-year follow-up study of patients who had double valve replacement with the St. Jude Medical prosthesis. J Thorac Cardiovasc Surg (1989) 0.81
Coronary sinus cardioplegia: clinical trial with only retrograde approach. Ann Thorac Surg (1992) 0.81
Results of heart transplantation for active lymphocytic myocarditis. J Heart Transplant (1990) 0.81
Myocardial carnitine in end-stage congestive heart failure. Am J Cardiol (1989) 0.80
Intrathoracic paraganglioma arising from aorticosympathetic paraganglion. Arch Surg (1976) 0.80
Response of the human body to the first permanent implant of the Jarvik-7 Total Artificial Heart. Trans Am Soc Artif Intern Organs (1983) 0.80
OPCAB surgery: a critical review of two different categories of pre-operative ejection fraction. Eur J Cardiothorac Surg (2001) 0.80
Antibiotic prophylaxis in open-heart surgery patients: comparison of cefamandole and cefuroxime. Drug Intell Clin Pharm (1987) 0.80
Outcomes of hepatitis C positive (HCV+) heart transplant recipients. Transplant Proc (1997) 0.80
Clinical and hemodynamic results with the St. Jude medical aortic valve prosthesis. Surg Forum (1979) 0.80
Frequency of success and complications of coronary angioplasty of a stenosis at the ostium of a branch vessel. Am J Cardiol (1991) 0.80
Percutaneous transluminal coronary angioplasty in the setting of large intracoronary thrombi. Am J Cardiol (1990) 0.80
Endobronchial metastasis from cancer of the breast. Chest (1978) 0.80
Coarctation of the aorta associated with aortic valvular atresia. Circulation (1975) 0.79
Myocardial vs serum digoxin concentrations in infants and adults. Am J Dis Child (1982) 0.79
Effects of ventricular fibrillation on coronary blood flow and myocardial metabolism. J Thorac Cardiovasc Surg (1977) 0.79
The comparative influence of prophylactic antibiotics on the prothrombin response to warfarin in the postoperative prosthetic cardiac valve patient. Cefamandole, cefazolin, vancomycin. Ann Surg (1987) 0.79
Evaluation of 7,000+ patients with two different routes of cardioplegia. Ann Thorac Surg (1997) 0.79
Registry report. Use of total artificial hearts: summary of world experience, 1969-1991. ASAIO J (1993) 0.79
Pulmonary pseudotumor caused by actinomycosis. Tex Med (1976) 0.79
Results with retrograde delivery of cardioplegia for myocardial protection during cardiac surgery. J Cardiovasc Surg (Torino) (1993) 0.79
Cardiac electrophysiologic and hemodynamic correlates of neurally mediated syncope. Am J Cardiol (1989) 0.79
Course guidelines for minimally invasive cardiac surgery. STS/AATS Ad Hoc Committee on New Technology Assessment. American Association for Thoracic Surgery. J Thorac Cardiovasc Surg (1998) 0.79
Blunt traumatic rupture of the atria. J Thorac Cardiovasc Surg (1976) 0.79